Skip to main content
. Author manuscript; available in PMC: 2020 Jan 1.
Published in final edited form as: Laryngoscope. 2018 Sep 24;129(1):154–161. doi: 10.1002/lary.27340

Table II.

Adjusted hazard ratios for oral cavity and laryngeal cancers

Oral Cavity Laryngeal


HR (95% CI) p-value HR (95% CI) p-value
Subtype
 Atypical 1.00 1.00
 Basal 0.70 (0.37, 1.32) 0.265 0.93 (0.18, 4.83) 0.935
 Classical 0.91 (0.44, 1.86) 0.793 4.32 (1.77, 10.54) 0.001
 Mesenchymal 1.05 (0.56, 1.96) 0.888 2.51 (0.91, 6.91) 0.076
Stage
 IV 1.00 1.00
 I–II 0.83 (0.53, 1.3) 0.415 0.89 (0.25, 3.17) 0.864
 III 1.03 (0.64, 1.68) 0.893 0.98 (0.41, 2.38) 0.973
Gender
 Male 1.00 1.00
 Female 1.13 (0.75, 1.69) 0.558 4.2 (1.99, 8.90) <0.001
Race
 White 1.00 1.00
 Non-White 1.36 (0.73, 2.52) 0.328 1.87 (0.82, 4.25) 0.135
Smoking
 Current 1.00 1.00
 Never/Former 0.74 (0.50, 1.11) 0.148 0.52 (0.26, 1.04) 0.064

CI: Confidence interval; HR: Hazards ratio